These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36263842)
1. Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies. Boot MV; Schaapveld M; Van den Broek EC; Hijmering NJ; Group P; Van der Oord K; Van Leeuwen FE; Dinmohamed AG; Koens L; De Jong D Haematologica; 2023 May; 108(5):1349-1358. PubMed ID: 36263842 [TBL] [Abstract][Full Text] [Related]
2. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly. Wang E; Papavassiliou P; Sebastian S Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037 [TBL] [Abstract][Full Text] [Related]
3. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases. Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994 [TBL] [Abstract][Full Text] [Related]
4. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities. Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074 [TBL] [Abstract][Full Text] [Related]
5. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma. Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043 [TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of EBV-positive classic Hodgkin lymphoma and B-cell lymphomas of different clonal origins: A case report and literature review. Karube K; Takatori M; Kohno K; Tomoyose T; Ohshiro K; Nakazato I Pathol Int; 2020 Nov; 70(11):893-898. PubMed ID: 32881147 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas. Kim SJ; Hyeon J; Cho I; Ko YH; Kim WS Cancer Res Treat; 2019 Apr; 51(2):611-622. PubMed ID: 30025443 [TBL] [Abstract][Full Text] [Related]
8. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana. Chipidza FE; Kayembe MKA; Nkele I; Efstathiou JA; Chabner BA; Abramson J; Dryden-Peterson SL; Sohani AR JCO Glob Oncol; 2021 Sep; 7():1620-1632. PubMed ID: 34860565 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: A Single-Centre Experience. Virga B; Pinczés L; Illés Á; Miltényi Z; Magyari F; Méhes G; Simon Z Cureus; 2024 Jun; 16(6):e63307. PubMed ID: 39070524 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated nodal malignant lymphoma in Thailand. Mitarnun W; Pradutkanchana J; Ishida T Asian Pac J Cancer Prev; 2004; 5(3):268-72. PubMed ID: 15373705 [TBL] [Abstract][Full Text] [Related]
12. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic approach for classic Hodgkin lymphoma in small samples with an emphasis on PD-L1 expression and EBV harboring in tumor cells: a brief review from morphology to biology. Takahara T; Sakakibara A; Tsuyuki Y; Satou A; Kato S; Nakamura S J Clin Exp Hematop; 2023; 63(2):58-64. PubMed ID: 37380470 [TBL] [Abstract][Full Text] [Related]
14. Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma. Hollander P; Ginman B; Molin D; Enblad G; Amini RM; Glimelius I Immunobiology; 2020 Jan; 225(1):151872. PubMed ID: 31787352 [TBL] [Abstract][Full Text] [Related]
15. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions. Shiraiwa S; Kikuti YY; Carreras J; Kondo Y; Ohmachi K; Ogawa Y; Kawada H; Sato S; Gion Y; Sato Y; Nakamura N; Ando K Am J Surg Pathol; 2022 Aug; 46(8):1017-1024. PubMed ID: 35848760 [TBL] [Abstract][Full Text] [Related]
16. Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review. Zehr B; Brannock K; Wyma R; Kahwash SB Diagn Pathol; 2023 Feb; 18(1):28. PubMed ID: 36814281 [TBL] [Abstract][Full Text] [Related]
17. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms. Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109 [TBL] [Abstract][Full Text] [Related]
18. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365 [TBL] [Abstract][Full Text] [Related]
19. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining. Ishtiaq S; Hassan U; Mushtaq S; Akhtar N Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215 [TBL] [Abstract][Full Text] [Related]
20. Adoptive T-cell therapy for Hodgkin lymphoma. Ho C; Ruella M; Levine BL; Svoboda J Blood Adv; 2021 Oct; 5(20):4291-4302. PubMed ID: 34610100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]